Current Evidence on Treatment of Patients With Chronic Systolic Heart Failure and Renal Insufficiency
Open accessAbstract
Chronic kidney disease (CKD) is increasingly prevalent in patients with chronic systolic heart failure. Therefore, evidence-based therapies are more and more being used in patients with some degree of renal dysfunction. However, most pivotal randomized clinical trials specifically excluded patients with (severe) renal dysfunction. The benefit of these evidence-based therapies in this high-risk patient group is largely unknown. This paper reviews data from randomized clinical trials in systolic heart failure and the interactions between baseline renal dysfunction and the effect of randomized treatment. It highlights that most evidence-based therapies show consistent outcome benefit in patients with moderate renal insufficiency (stage 3 CKD), whereas there are very scarce data on patients with severe (stage 4 to 5 CKD) renal insufficiency. If any, the outcome benefit might be even greater in stage 3 CKD compared with those with relatively preserved renal function. However, prescription of therapies should be individualized with consideration of possible harm and benefit, especially in those with stage 4 to 5 CKD where limited data are available.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Underutilization of renin-angiotensin system blockers and mineralocorticoid receptor antagonists is well recognized in patients with CKD, and the benefits of β-blockers are attenuated in patients with marked reductions in eGFR.
“Specifically, underutilization of renin-angiotensin system blockers and mineralocorticoid receptor antagonists is well recognized in patients with CKD and, more recently, evidence has been presented that the benefits of β-blockers are attenuated in patients with marked reductions in eGFR.”
From Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF (2021) · cites this paper as [17]
Previous studies have shown that worsening kidney function identified by even modest increases in creatinine (or equivalent reductions in eGFR) is associated with worse cardiovascular outcomes in patients with HFrEF.
“The reduced risk of doubling of creatinine concentration is notable, given that previous studies have shown that worsening kidney function identified by even modest increases in creatinine (or equivalent reductions in eGFR) are associated with worse cardiovascular outcomes in patients with HFrEF.3,17,18,22”
From Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF (2021) · cites this paper as [17]
Patients with CKD often cannot be treated with alternative life-saving therapies.
“That the benefits of dapagliflozin on the primary and secondary cardiovascular outcomes were consistent in patients with and without low eGFR is important, because these patients are at much higher risk than patients with preserved kidney function (as observed in this study) and often cannot be treated with alternative life-saving therapies.”
From Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF (2021) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536 · see citing works
Self-citationLevey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633 · see citing works
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369 · see citing works
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214 · see citing works
Self-citationMoss, A. J., Zaręba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,885 · see citing works
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879 · see citing works
Self-citationAmiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552 · see citing works
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
Cleland, J. G. F., Daubert, J., Erdmann, E., Freemantle, N., Gras, D., KAPPENBERGER, L. J., & Tavazzi, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050496 · Cited by 6,258 · see citing works
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,109 · see citing works
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941 · see citing works
Self-citationCardiac Resynchronization in Chronic Heart Failure
Abraham, W. T., Fisher, W. G., Smith, A. L., Delurgio, D. B., Leon, A. R., Loh, E., Kocovic, D. Z., Packer, M., Clavell, A. L., Hayes, D. L., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013168 · Cited by 4,648 · see citing works
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165 · see citing works
CARDIAC RESYNCHRONIZATION IN CHRONIC HEART FAILURE
Braham, W. I. T. A., Isher, W. E. G. F., Mith, L. S., Elurgio, D. A. B. D., Eon, A. N. R. L., Oh, E., Ocovic, D. U. Z. K., Acker, M. G., Lavell, L. C., Ayes, D. A. L. H., et al. (2002) · Cited by 3,808 · see citing works
Swedberg, K. B., & KJEKSHUS, J. K. (1988) · The American Journal of Cardiology · doi:10.1016/s0002-9149(88)80087-0 · Cited by 3,762 · see citing works
The AVID Investigators (1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372202 · Cited by 3,221 · see citing works
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
Moss, A. J., Hall, W. J., Cannom, D. S., Klein, H., Brown, M. W., Daubert, J. P., Estes, N. A. M., Foster, E., Greenberg, H., Higgins, S. L., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906431 · Cited by 3,157 · see citing works
Eplerenone in patients with systolic heart failure and mild symptoms
Zannad, F., McMurray, J. J. V., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., Pocock, S. J., & Pitt, B. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009492 · Cited by 3,111 · cited 2× · see citing works
“This regimen was found to be highly effective, because the incidence of hyperkalemia leading to study drug withdrawal was not different from placebo (7).”
BackgroundSelf-citationThe effect of digoxin on mortality and morbidity in patients with heart failure
(1997) · New England Journal of Medicine · doi:10.1056/nejm199702203360801 · Cited by 3,016 · see citing works
Yusuf, S., Pfeffer, M. A., Swedberg, K., Granger, C. B., Held, P., McMurray, J. J., Michelson, E. L., Olofsson, B., & Östergren, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14285-7 · Cited by 2,994 · see citing works
Self-citationThe Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F. M., Remme, W. J., Cody, R. J., Castaigne, A., Pérez, A. J. P., Palensky, J., & Wittes, J. T. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927 · see citing works
Self-citationESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs105 · Cited by 2,644 · see citing works
Self-citationMcMurray, J. J., Östergren, J., Swedberg, K., Granger, C. B., Held, P., Michelson, E. L., Olofsson, B., Yusuf, S., & Pfeffer, M. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14283-3 · Cited by 2,604 · see citing works
Self-citationIvabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Swedberg, K., Komajda, M., Böhm, M., Borer, J. S., Ford, I., Dubost-Brama, A., Lerebours, G., & Tavazzi, L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61198-1 · Cited by 2,563 · see citing works
Pfeffer, M. A., McMurray, J. J. V., Velazquez, E. J., Rouleau, J.-L., Køber, L., Maggioni, A. P., Solomon, S. D., Swedberg, K., Van de Werf, F., White, H., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa032292 · Cited by 2,471 · see citing works
Self-citationEffect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400 · see citing works
Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy
Kadish, A. H., Dyer, A. R., Daubert, J. P., Quigg, R. J., Estes, N. A. M., Anderson, K. P., Calkins, H. G., Hoch, D., Goldberger, J. J., Shalaby, A. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033088 · Cited by 2,064 · see citing works
Oss, J. M., Areba, W. O. Z., Ackson, W. J., Lein, H. E. K., Ilber, D. A. J. W., Annom, D. A. S. C., Ames, J. M., Aubert, P., Iggins, S. T. L. H., Rown, M. A. W. B., et al. (2002) · Cited by 2,026 · see citing works
Ronco, C., Haapio, M., House, A. A., Anavekar, N. S., & Bellomo, R. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.051 · Cited by 1,989 · see citing works
Pitt, B., Poole-Wilson, P. A., Segal, R., Martínez, F. A., Dickstein, K., Camm, A. J., Konstam, M. A., Riegger, G. A. J., Klinger, G. H., Neaton, J. D., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02213-3 · Cited by 1,954 · see citing works
Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure
Tang, A. S. L., Wells, G. A., Talajic, M., Arnold, M. O., Sheldon, R., Connolly, S., Hohnloser, S. H., Nichol, G., Birnie, D. H., Sapp, J. L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1009540 · Cited by 1,859 · see citing works
Granger, C. B., McMurray, J. J., Yusuf, S., Held, P., Michelson, E. L., Olofsson, B., Östergren, J., Pfeffer, M. A., & Swedberg, K. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14284-5 · Cited by 1,686 · see citing works
Self-citationYoung, J. B., Abraham, W. T., & Smith, A. L. (2003) · ACC Current Journal Review · doi:10.1016/j.accreview.2003.08.087 · Cited by 1,661 · see citing works
Pitt, B., Segal, R., Martínez, F. A., Meurers, G., Cowley, A. J., Thomas, I., DEEDWANIA, P. C., Ney, D. E., Snavely, D. B., & Chang, P. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01187-2 · Cited by 1,656 · see citing works
Flather, M. D., Shibata, M. C., Coats, A. J. S., van Veldhuisen, D. J., Parkhomenko, A. N., Borbola, J., Solal, A. C., Dumitrascu, D. L., Ferrari, R., Lechat, P. P., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi115 · Cited by 1,649 · see citing works
Canadian Implantable Defibrillator Study (CIDS)
Connolly, S. J., Gent, M., Roberts, R. S., Dorian, P., Roy, D., Sheldon, R. S., Mitchell, L. B., Green, M. S., Klein, G. J., & O’Brien, B. (2000) · Circulation · doi:10.1161/01.cir.101.11.1297 · Cited by 1,601 · see citing works
Mann, J. F. E., Schmieder, R. E., McQueen, M., Dyal, L., Schumacher, H., Pogue, J. M., Wang, X., Maggioni, A. P., Budaj, A., Chaithiraphan, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61236-2 · Cited by 1,581 · see citing works
Rosuvastatin in older patients with systolic heart failure
Kjekshus, J., Apetrei, E., Barrios, V., Böhm, M., Cleland, J. G. F., Cornel, J. H., Dunselman, P., Fonseca, C., Goudev, A., Grande, P., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706201 · Cited by 1,487 · see citing works
Self-citationGoodpasture syndrome during the course of a Schönlein-Henoch purpura
Carreras, L., Poveda, R., Bas, J., Mestre, M., Rama, I., & Carrera, M. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32799 · Cited by 1,474 · see citing works
Kück, K., Cappato, R., Siebels, J., & Rüppel, R. (2000) · Circulation · doi:10.1161/01.cir.102.7.748 · Cited by 1,474 · see citing works
Dickstein, K., & KJEKSHUS, J. K. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09895-1 · Cited by 1,200 · see citing works
GISSI-HF investigators (2008) · The Lancet · doi:10.1016/s0140-6736(08)61240-4 · Cited by 1,106 · see citing works
Fox, K., Ford, I., Steg, P. G., Tendera, M., & Ferrari, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61170-8 · Cited by 1,099 · see citing works
Aliskiren, ALTITUDE, and the Implications for ATMOSPHERE
McMurray, J. J. V., Abraham, W. T., Dickstein, K., Køber, L., Massie, B. M., & Krum, H. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs033 · Cited by 1,092 · see citing works
Self-citationRenal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure
Hillege, H. L., Nitsch, D., Pfeffer, M. A., Swedberg, K., McMurray, J. J. V., Yusuf, S., Granger, C. B., Michelson, E. L., Östergren, J., Cornel, J. H., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.580506 · Cited by 945 · see citing works
Self-citationKonstam, M. A., Neaton, J. D., Dickstein, K., Drexler, H., Komajda, M., Martinez, F. A., Riegger, G. A., Malbecq, W., Smith, R. D., Guptha, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61913-9 · Cited by 646 · see citing works
Primary Prevention of Sudden Cardiac Death in Idiopathic Dilated Cardiomyopathy
Bänsch, D., Antz, M., Boczor, S., Volkmer, M., Tebbenjohanns, J., Seidl, K., Block, M. S., Gietzen, F. H., Berger, J., & Kück, K. (2002) · Circulation · doi:10.1161/01.cir.0000012350.99718.ad · Cited by 644 · see citing works
Worsening Renal Function and Prognosis in Heart Failure: Systematic Review and Meta-Analysis
Damman, K., Navis, G. J., Voors, A. A., Asselbergs, F. W., Smilde, T. D. J., Cleland, J. G. F., van Veldhuisen, D. J., & Hillege, H. L. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.04.008 · Cited by 604 · see citing works
Self-citationCarvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy
Cice, G., Ferrara, L., D’Andrea, A., D’Isa, S., Benedetto, A. D., Cittadini, A., Russo, P. E., Golino, P., & Calabrò, R. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00241-9 · Cited by 534 · see citing works
Leclercq, C. (2002) · European Heart Journal · doi:10.1053/euhj.2002.3232 · Cited by 445 · see citing works
Metra, M., Nodari, S., Parrinello, G., Bordonali, T., Bugatti, S., Danesi, R., Fontanella, B., Lombardi, C., Milani, P., Verzura, G., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.01.011 · Cited by 379 · see citing works
Albuminuria in chronic heart failure: prevalence and prognostic importance
Jackson, C. E., Solomon, S. D., Gerstein, H. C., Zetterstrand, S., Olofsson, B., Michelson, E. L., Granger, C. B., Swedberg, K. B., Pfeffer, M. A., Yusuf, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61378-7 · Cited by 308 · see citing works
Self-citationTorasemide in Chronic Heart Failure: Results of the TORIC Study
Cosín, J., & Dı́ez, J. (2002) · European Journal of Heart Failure · doi:10.1016/s1388-9842(02)00122-8 · Cited by 277 · see citing works
Vardeny, O., Wu, D. H., Desai, A. S., Rossignol, P., Zannad, F. M., Pitt, B., & Solomon, S. D. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.048 · Cited by 275 · see citing works
Self-citationMurray, M. D., Deer, M. M., Ferguson, J. A., Dexter, P. R., Bennett, S. J., Perkins, S. M., Smith, F. E., Lane, K. A., Adams, L. D., Tierney, W. M., et al. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00903-2 · Cited by 254 · see citing works
Eschalier, R., McMurray, J. J. V., Swedberg, K. B., van Veldhuisen, D. J., Krum, H., Pocock, S., Shi, H. H., Vincent, J., Rossignol, P., Zannad, F. M., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.04.086 · Cited by 249 · see citing works
Self-citationTestani, J. M., Kimmel, S. E., Dries, D. L., & Coca, S. G. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.111.963256 · Cited by 245 · see citing works
Goldenberg, I., Moss, A. J., McNitt, S. A., Zaręba, W., Andrews, M. L., Hall, W. J., Greenberg, H., & Case, R. B. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.03.025 · Cited by 209 · see citing works
Renal Dysfunction in Patients With Heart Failure With Preserved Versus Reduced Ejection Fraction
McAlister, F. A., Ezekowitz, J. A., Tarantini, L., Squire, I. B., Michel Komajda, N., Bayés‐Genís, A., Gotsman, I., WHALLEY, G. A., Earle, N. J., Poppe, K., et al. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.111.966242 · Cited by 202 · see citing works
Ljungman, S., Kjekshus, J., & Swedberg, K. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91194-9 · Cited by 193 · see citing works
Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison
Poole‐Wilson, P. A. (1998) · European Heart Journal · doi:10.1053/euhj.1997.0839 · Cited by 188 · see citing works
Tokmakova, M. P., Skali, H., Kenchaiah, S., D, E. B. M., Rouleau, J. L., Packer, M., Chertow, G. M., Moyé, L. A., Pfeffer, M. A., & Solomon, S. D. (2004) · Circulation · doi:10.1161/01.cir.0000149806.01354.bf · Cited by 182 · see citing works
Cice, G., Benedetto, A. D., D’Isa, S., D’Andrea, A., Marcelli, D., Gatti, E., & Calabrò, R. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.03.105 · Cited by 171 · see citing works
Incidence and Predictors of Hyperkalemia in Patients With Heart Failure
Desai, A. S., Swedberg, K., McMurray, J. J. V., Granger, C. B., Yusuf, S., Young, J. B., Dunlap, M. E., Solomon, S. D., Hainer, J. W., Olofsson, B., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.067 · Cited by 170 · see citing works
Self-citationPharmacotherapy for Heart Failure in Patients with Renal Insufficiency
Shlipak, M. G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-11-200306030-00013 · Cited by 166 · see citing works
Knight, E. L., Glynn, R. J., McIntyre, K. M., Mogun, H., & Avorn, J. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70009-8 · Cited by 164 · see citing works
Hillege, H. L. (2003) · European Heart Journal · doi:10.1016/s0195-668x(02)00526-2 · Cited by 164 · see citing works
Rossignol, P., Cleland, J. G. F., Bhandari, S., Tala, S., Gustafsson, F., Fay, R., Lamiral, Z., Dobre, D., Pitt, B., & Zannad, F. M. (2011) · Circulation · doi:10.1161/circulationaha.111.028282 · Cited by 159 · see citing works
Self-citationRenal Function, Digoxin Therapy, and Heart Failure Outcomes
Shlipak, M. G., Smith, G. L., Rathore, S. S., Massie, B. M., & Krumholz, H. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000135121.81744.75 · Cited by 149 · see citing works
Anand, I. S., Bishu, K. G., Rector, T. S., Ishani, A., Kuskowski, M. A., & Cohn, J. N. (2009) · Circulation · doi:10.1161/circulationaha.109.853648 · Cited by 145 · see citing works
Damman, K., Chuen, M. J. N. K., MacFadyen, R. J., Lip, G. Y. H., Gaze, D. C., Collinson, P. O., Hillege, H. L., van Oeveren, W., Voors, A. A., & van Veldhuisen, D. J. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.10.065 · Cited by 132 · see citing works
Self-citationMasson, S., Latini, R., Milani, V., Moretti, L., Rossi, M. G., Carbonieri, E., Frisinghelli, A., Minneci, C., Valisi, M., Maggioni, A. P., et al. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.881805 · Cited by 129 · see citing works
Swedberg, K. B., Eneroth, P. H. E., KJEKSHUS, J. K., & Snapinn, S. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90475-g · Cited by 114 · see citing works
Taylor, A. L., Ziesche, S., Yancy, C. W., Carson, P., Ferdinand, K., Taylor, M., Adams, K., Olukotun, A. Y., Ofili, E., Tam, S. W., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.644013 · Cited by 114 · see citing works
Ghali, J. K., Wikstrand, J., van Veldhuisen, D. J., Fagerberg, B., Goldstein, S., Hjalmarson, Å. C., Johansson, P., KJEKSHUS, J. K., Ohlsson, L., Samuelsson, O. G., et al. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.11.003 · Cited by 106 · see citing works
Castagno, D., Jhund, P. S., McMurray, J. J. V., Lewsey, J., Erdmann, E., Zannad, F. M., Remme, W. J., Lopez-Sendon, J. L., Lechat, P. P., Folláth, F., et al. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq038 · Cited by 104 · see citing works
Self-citationBoerrigter, G., Costello‐Boerrigter, L. C., Abraham, W. T., Sutton, M. G. S. J., Heublein, D. M., Kruger, K. M., Hill, M. R. S., McCullough, P. A., & Burnett, J. C. J. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.03.009 · Cited by 103 · see citing works
Efficacy and Safety of Carvedilol in Treatment of Heart Failure with Chronic Kidney Disease
Wali, R. K., Iyengar, M. K., Beck, G. J., Chartyan, D. M., Chonchol, M., Lukas, M. A., Cooper, C. J., Himmelfarb, J., Weir, M. R., Berl, T., et al. (2010) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.932558 · Cited by 103 · see citing works
Solal, A. C., Kotecha, D., van Veldhuisen, D. J., Babalis, D. S., Böhm, M., Coats, A. J. S., Roughton, M., Poole-Wilson, P. A., Tavazzi, L., & Flather, M. D. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp104 · Cited by 100 · see citing works
Bowling, C. B., Sanders, P. W., Allman, R. M., Rogers, W. J., Patel, K., Aban, I. B., Rich, M. W., Pitt, B., White, M., Bakris, G. C., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.12.056 · Cited by 85 · see citing works
Massie, B. M., Armstrong, P. W., Cleland, J. G. F., Horowitz, J. D., Packer, M., Poole-Wilson, P. A., & Rydén, L. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.2.165 · Cited by 83 · see citing works
Taylor, J. (2007) · PubMed · Cited by 82 · see citing works
Dominance of Furosemide for Loop Diuretic Therapy in Heart Failure
Bikdeli, B., Strait, K. M., Dharmarajan, K., Partovian, C., Coca, S. G., Kim, N. V., Li, S., Testani, J. M., Khan, U., & Krumholz, H. M. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.12.043 · Cited by 62 · see citing works
Renal Function in Outpatients With Chronic Heart Failure
Waldum, B., Westheim, A. S., Sandvik, L., Flønæs, B., Grundtvig, M., Gullestad, L. L., Hole, T., & Os, I. (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.01.001 · Cited by 54 · see citing works
Heywood, J. T., Fonarow, G. C., Yancy, C. W., Albert, N. M., Curtis, A. B., Stough, W. G., Gheorghiade, M., McBride, M. L., Mehra, M. R., O’Connor, C. M., et al. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.12.016 · Cited by 52 · see citing works
Goldenberg, I., Moss, A. J., McNitt, S. A., Barsheshet, A., Gray, D. A., Andrews, M. L., Brown, M. W., Zaręba, W., Sze, E. Y., Solomon, S. D., et al. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.09.005 · Cited by 46 · see citing works
Cardiac Resynchronization Therapy in CKD
Garg, N., Thomas, G., Jackson, G. R., Rickard, J., Nally, J. V., Tang, W. H. W., & Navaneethan, S. D. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00750113 · Cited by 34 · see citing works
Self-citationEnalapril for congestive heart failure
KJEKSHUS, J. K., & Swedberg, K. B. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90414-1 · Cited by 22 · see citing works
Pharmacologic Management of Chronic Reno-Cardiac Syndrome
Hawwa, N., Schreiber, M. J., & Tang, W. H. W. (2012) · Current Heart Failure Reports · doi:10.1007/s11897-012-0122-8 · Cited by 19 · see citing works
Self-citationKümler, T., Gislason, G., Køber, L., Gustafsson, F., Schou, M., & Torp-Pedersen, C. T. (2011) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-11-37 · Cited by 11 · see citing works
BAYESIAN META-ANALYSIS ON MEDICAL DEVICES: APPLICATION TO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
Youn, J.-H., Lord, J. L., Hemming, K., Girling, A. J., & Buxton, M. J. (2012) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462312000037 · Cited by 5 · see citing works
Young, J. B. (2003) · JAMA · doi:10.1001/jama.289.20.2685 · Cited by 4 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- Damman et al. JACC Vol. 63, No. 9, 2014 Treatment of Patients With Heart Failure and Renal Insufficiency March 11, 2014:853-71
Cited by
Sorted by citations
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 19,618 · see citing works
Self-citation2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab368 · Cited by 13,344 · see citing works
Self-citation2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Authors/Task Force Members:, McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2333 · Cited by 2,274 · see citing works
Self-citationRangaswami, J., Bhalla, V., Blair, J. E., Chang, T. I., Costa, S. P., Lentine, K. L., Lerma, E. V., Mezue, K. N., Molitch, M. E., Müllens, W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000664 · Cited by 1,479 · see citing works
Self-citationThe kidney in heart failure: an update
Damman, K., & Testani, J. M. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv010 · Cited by 519 · see citing works
Self-citationMacdougall, I. C., Bircher, A. J., Eckardt, K., Obrador, G. T., Pollock, C. A., Stenvinkel, P., Swinkels, D. W., Wanner, C., Weiß, G., Chertow, G. M., et al. (2016) · Kidney International · doi:10.1016/j.kint.2015.10.002 · Cited by 488 · see citing works
Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure
Damman, K., Gori, M., Claggett, B. L., Jhund, P. S., Senni, M., Lefkowitz, M. P., PRESCOTT, M. F., Shi, V. C., Rouleau, J. L., Swedberg, K. B., et al. (2018) · JACC Heart Failure · doi:10.1016/j.jchf.2018.02.004 · Cited by 460 · see citing works
Self-citationHouse, A. A., Wanner, C., Sarnak, M. J., Piña, I. L., McIntyre, C. W., Komenda, P. V. J., Kasiske, B. L., Deswal, A. M., deFilippi, C. R., Cleland, J. G. F., et al. (2019) · Kidney International · doi:10.1016/j.kint.2019.02.022 · Cited by 468 · see citing works
Jhund, P. S., Solomon, S. D., Docherty, K. F., Heerspink, H. J. L., Anand, I. S., Böhm, M., Chopra, V., de Boer, R. A., Desai, A. S., Ge, J., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.050391 · Cited by 307 · see citing works
Self-citationBeldhuis, I. E., Lam, C. S. P., Testani, J. M., Voors, A. A., Spall, H. G. C. V., ter Maaten, J. M., & Damman, K. (2022) · Circulation · doi:10.1161/circulationaha.121.052792 · Cited by 233 · see citing works
Self-citationJCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Kitai, T., Kohsaka, S., Kato, T., Kato, E. T., Sato, K., TERAMOTO, K., Yaku, H., Akiyama, E., Ando, M., Izumi, C., et al. (2025) · Circulation Journal · doi:10.1253/circj.cj-25-0002 · Cited by 227 · see citing works
Müllens, W., Martens, P., Testani, J. M., Tang, W. H. W., Skouri, H. N., Verbrugge, F. H., Fudim, M., Iacoviello, M., Franke, J., Flammer, A. J., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2471 · Cited by 148 · see citing works
Self-citationvan Veldhuisen, D. J., Ruilope, L. M., Maisel, A. S., & Damman, K. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv588 · Cited by 139 · see citing works
Self-citationGuía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2022) · Revista Española de Cardiología · doi:10.1016/j.recesp.2021.11.027 · Cited by 132 · see citing works
Self-citationEdner, M., Benson, L., Dahlström, U., & Lund, L. H. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv268 · Cited by 112 · see citing works
Vader, J. M., LaRue, S., Stevens, S. R., Mentz, R. J., DeVore, A. D., Lala, A., Groarke, J. D., AbouEzzeddine, O. F., Dunlay, S. M., Grodin, J. L., et al. (2016) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2016.04.014 · Cited by 95 · see citing works
Renal dysfunction in cardiovascular diseases and its consequences
Deferrari, G., Cipriani, A., & Porta, E. L. (2020) · Journal of Nephrology · doi:10.1007/s40620-020-00842-w · Cited by 97 · see citing works
The Cardio-Kidney Patient: Epidemiology, Clinical Characteristics and Therapy
Schuett, K. A., Marx, N., & Lehrke, M. (2023) · Circulation Research · doi:10.1161/circresaha.122.321748 · Cited by 84 · see citing works
Mazurek, J. A., & Jessup, M. L. (2015) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2015.08.001 · Cited by 77 · see citing works
Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure
Kotecha, D., Gill, S. K., Flather, M. D., Holmes, J., Packer, M., Rosano, G., Böhm, M., McMurray, J. J. V., Wikstrand, J., Anker, S. D., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.09.059 · Cited by 71 · see citing works
Self-citationPrimeßnig, U., Schönleitner, P., Höll, A., Pfeiffer, S., Bracic, T., Rau, T., Kapl, M., Stojaković, T., Glasnov, T. N., Leineweber, K., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.524 · Cited by 70 · see citing works
Mazurek, J. A., & Jessup, M. L. (2016) · Heart Failure Clinics · doi:10.1016/j.hfc.2016.07.001 · Cited by 68 · see citing works
Management of Heart Failure in Advancing CKD: Core Curriculum 2018
House, A. A. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.12.006 · Cited by 67 · see citing works
Bashier, A. M., Hussain, A. K. B., Abdelgadir, E., Alawadi, F., Sabbour, H. M., & CHILTON, R. J. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0476-0 · Cited by 63 · see citing works
Aimo, A., Januzzi, J. L., Vergaro, G., Ripoli, A., Latini, R., Masson, S., Magnoli, M., Anand, I. S., Cohn, J. N., Tavazzi, L., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.10.079 · Cited by 60 · see citing works
Self-citationHein, A. M., Scialla, J. J., Edmonston, D. L., Cooper, L. B., DeVore, A. D., & Mentz, R. J. (2019) · JACC Heart Failure · doi:10.1016/j.jchf.2019.02.009 · Cited by 59 · see citing works
2026 ESC Guidelines for the management of heart failure
Køber, L., Adamo, M., Ruwald, A., Tomasoni, D., Anderson, L., Andersson, C., Brugts, J. J., Chioncel, O. D., Donal, E., Ferdinandy, P., et al. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag100 · Cited by 91 · see citing works
Self-citationThe Cardio-Renal Interrelationship
Boudoulas, K. D., Triposkiadis, F. K., Parissis, J., Butler, J., & Boudoulas, H. K. (2016) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2016.12.003 · Cited by 58 · see citing works
Hohendanner, F., Messroghli, D., Bode, D., Blaschke, F., Parwani, A. S., Boldt, L., & Heinzel, F. R. (2018) · ESC Heart Failure · doi:10.1002/ehf2.12260 · Cited by 48 · see citing works
JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Kitai, T., Kohsaka, S., Kato, T., Kato, E. T., Sato, K., TERAMOTO, K., Yaku, H., Akiyama, E., Ando, M., Izumi, C., et al. (2025) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2025.02.014 · Cited by 49 · see citing works
The role of the kidney in acute and chronic heart failure
Ruocco, G. M., Palazzuoli, A., & ter Maaten, J. M. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09870-6 · Cited by 47 · see citing works
Renal function monitoring in heart failure – what is the optimal frequency? A narrative review
Al‐Naher, A., Wright, D. J., Devonald, M. A. J., & Pirmohamed, M. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13434 · Cited by 45 · see citing works
Heart failure: an historical perspective
Ferrari, R., Balla, C., & Fucili, A. (2016) · European Heart Journal Supplements · doi:10.1093/eurheartj/suw042 · Cited by 39 · see citing works
Burden and challenges of heart failure in patients with chronic kidney disease. A call to action
Romero-González, G. A., Ravassa, S., González, O., Lorenzo, I., Rojas, M. A., García-Trigo, I., Garcı́a-Fernández, N., Lavilla, J., Martín-Moreno, P. L., López, B., et al. (2019) · Nefrología · doi:10.1016/j.nefro.2019.10.005 · Cited by 37 · see citing works
Mark, P. B., Mangion, K., Rankin, A. J., Rutherford, E., Lang, N. N., Petrie, M. C., Stoumpos, S., & Patel, R. K. (2022) · Clinical Kidney Journal · doi:10.1093/ckj/sfac146 · Cited by 37 · see citing works
Feng, Y., Yin, Y., Deng, R., & Li, H. (2020) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13243 · Cited by 35 · see citing works
Heart Failure and Kidney Disease
Grande, D., Gioia, M. I., Terlizzese, P., & Iacoviello, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/5584_2017_126 · Cited by 34 · see citing works
Potential Expanded Indications for Neprilysin Inhibitors
Riddell, E., & Vader, J. M. (2017) · Current Heart Failure Reports · doi:10.1007/s11897-017-0327-y · Cited by 32 · see citing works
Nguyen, M., Rumjaun, S., Lowe‐Jones, R., Ster, I. C., Rosano, G. M. C., Anderson, L., & Banerjee, D. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12796 · Cited by 32 · see citing works
Barriers to guideline mandated renin–angiotensin inhibitor use: focus on hyperkalaemia
Vijayakumar, S., Butler, J., & Bakris, G. L. (2019) · European Heart Journal Supplements · doi:10.1093/eurheartj/suy030 · Cited by 30 · see citing works
Fu, E. L., Uijl, A., Dekker, F. W., Lund, L. H., Savarese, G., & Carrero, J. J. (2020) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.007180 · Cited by 30 · see citing works
Pharmacological interventions for heart failure in people with chronic kidney disease
Lunney, M., Ruospo, M., Natale, P., Quinn, R. R., Ronksley, P. E., Konstantinidis, I., Palmer, S. C., Tonelli, M. A., Strippoli, G. F., & Ravani, P. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012466.pub2 · Cited by 33 · see citing works
Muneer, K., & Nair, A. (2016) · Indian Heart Journal · doi:10.1016/j.ihj.2016.08.007 · Cited by 28 · see citing works
Friedman, D. J., Singh, J. P., Curtis, J. P., Tang, W. H. W., Bao, H., Spatz, E. S., Hernandez, A. F., Patel, U. D., & Al‐Khatib, S. M. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.09.097 · Cited by 27 · see citing works
Self-citationGan, L., Lyu, X., Yang, X., Zhao, Z., Tang, Y., Chen, Y., Yao, Y., Hong, F., Xu, Z., Chen, J., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.877237 · Cited by 26 · see citing works
Chang, D., Xu, T., Zhang, S.-J., Cai, Y., Min, S., Zhao, Z., Lu, C., Wang, Y., & Ju, S. (2021) · Experimental Biology and Medicine · doi:10.1177/15353702211035058 · Cited by 26 · see citing works
Impaired Renal Function Affects Clinical Outcomes and Management of Patients with Heart Failure
Jenkins, R., Mandarano, L., Gugathas, S., Kaski, J. C., Anderson, L., & Banerjee, D. (2017) · ESC Heart Failure · doi:10.1002/ehf2.12185 · Cited by 25 · see citing works
What Physicians Need to Know About Renal Function in Outpatients with Heart Failure
Waldum-Grevbo, B. E. (2015) · Cardiology · doi:10.1159/000381012 · Cited by 22 · see citing works
Chen, X., Lu, G., Tang, K., Li, Q., & Gao, X. (2015) · Neuropeptides · doi:10.1016/j.npep.2015.03.003 · Cited by 22 · see citing works
Acute Cardiorenal Syndrome in Heart Failure: from Dogmas to Advances
Tang, W. H. W., & Kiang, A. (2020) · Current Cardiology Reports · doi:10.1007/s11886-020-01384-0 · Cited by 21 · see citing works
Self-citationEpidemiology and Risk Factors for Hyperkalaemia in Heart Failure
Grobbee, D. E., Filippatos, G. S., Desai, N. R., Coats, A. J. S., Pinto, F. J., Rosano, G. M. C., Cleland, J. G. F., Kammerer, J. A., & de Arellano, A. R. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14661 · Cited by 20 · see citing works
Biglane, J. B., Becnel, M. F., Ventura, H. O., & Krim, S. R. (2017) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2017.08.006 · Cited by 19 · see citing works
Weng, S., Chen, Y., Hsu, C., Lin, C., Tarng, D., & Lin, S. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.680098 · Cited by 19 · see citing works
Henrysson, J., Thunström, E. Ö., Chen, X., Fu, M. L. X., & Basic, C. (2022) · ESC Heart Failure · doi:10.1002/ehf2.14137 · Cited by 17 · see citing works
Suzuki, M., Matsue, Y., Izumi, S., Kimura, A., Hashimoto, T., Otomo, K., Saito, H., Suzuki, M., Kato, Y., & Funakoshi, R. (2017) · Heart and Vessels · doi:10.1007/s00380-017-1099-8 · Cited by 19 · see citing works
The Ascent of Mineralocorticoid Receptor Antagonists in Diabetic Nephropathy
Goenka, L., Padmanaban, R., & George, M. (2018) · Current Clinical Pharmacology · doi:10.2174/1574884713666181116100946 · Cited by 19 · see citing works
Response to Cardiac Resynchronization Therapy Across Chronic Kidney Disease Stages
ter Maaten, J. M., Martens, P., L’Hoyes, W., Maass, A. H., Damman, K., Dupont, M., & Müllens, W. (2019) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2019.07.005 · Cited by 19 · see citing works
Self-citationYue, T., Zheng, D., He, J., Xiong, S., Xu, J., & Hou, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1676988 · Cited by 18 · see citing works
Singal, G., Upadhyay, G. A., Borgquist, R., Friedman, D. J., Chatterjee, N. A., Kandala, J., Park, M. Y., Orencole, M. P., Dec, G. W., Picard, M. H., et al. (2015) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12685 · Cited by 18 · see citing works
Ameri, P., Marzo, V. D., Biondi‐Zoccai, G., Tricarico, L., Correale, M., Brunetti, N. D., Canepa, M., Ferrari, G. M. D., Castagno, D., & Porto, I. (2021) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvab088 · Cited by 17 · see citing works
Santobuono, V. E., Favale, S., D’Onofrio, A., Manzo, M., Calò, L., Bertini, M., Savarese, G., Santini, L., Russo, A. D., Lavalle, C., et al. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14416 · Cited by 16 · see citing works
Butt, J. H., Jhund, P. S., Henderson, A. D., Claggett, B. L., Desai, A. S., Lam, C. S. P., BRINKER, M. D., Schloemer, P., Viswanathan, P., Lage, A. Z., et al. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.3649 · Cited by 15 · see citing works
Self-citationPharmacological interventions for heart failure in people with chronic kidney disease
Ravani, P., Quinn, R. R., & Strippoli, G. F. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012466 · Cited by 16 · see citing works
Arrigo, M., Cippà, P. E., & Mebazaa, A. (2018) · Current Heart Failure Reports · doi:10.1007/s11897-018-0406-8 · Cited by 15 · see citing works
The role of mechanotransduction in heart failure pathobiology—a concise review
Krueger, W., Bender, N., Haeusler, M., & Henneberg, M. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-09915-1 · Cited by 14 · see citing works
Kim, H., Lee, M., Jo, S., Seo, W., Kim, S. E., Kim, K.-J., Choi, J., Ahn, H., Choi, D., & Ryu, K.-H. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0782 · Cited by 13 · see citing works
Martínez‐Milla, J., Cortés, M., Urquía, M. T., Castillo, M. L., Devesa, A., Rivero, A. L., Mariscal, M. L. M., Figuero, S. B., Peláez, J. A. F., & Tuñón, J. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00709-1 · Cited by 13 · see citing works
Kolkhof, P., Pook, E., Pavkovic, M., Kretschmer, A., Buchmüller, A., Tinel, H., Delbeck, M., Mondritzki, T., Wasnaire, P., Dinh, W., et al. (2019) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000677 · Cited by 12 · see citing works
Albert, N. M., Tyson, R., Hill, C. L., DeVore, A. D., Spertus, J. A., Duffy, C. I., Butler, J., Patterson, J. H., Hernandez, A. F., Williams, F. B., et al. (2021) · American Heart Journal · doi:10.1016/j.ahj.2021.01.017 · Cited by 12 · see citing works
Girerd, N., Zannad, F. M., & Rossignol, P. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.06.004 · Cited by 12 · see citing works
Self-citationWestland, H., Page, S. D., van Rijn, M. M., Aryal, S., Freedland, K. E., Lee, C. S., Strömberg, A., Vellone, E., Wiebe, D. J., Jaarsma, T., et al. (2022) · Heart & Lung · doi:10.1016/j.hrtlng.2022.06.001 · Cited by 11 · see citing works
Walgraeve, K., der Linden, L. R. V., Flamaing, J., Fagard, K., Spriet, I., & Tournoy, J. (2018) · European Geriatric Medicine · doi:10.1007/s41999-017-0019-x · Cited by 11 · see citing works
Novel biomarkers and therapies in cardiorenal syndrome
Latini, R., Aleksova, A., & Masson, S. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.01.010 · Cited by 11 · see citing works
Matsushita, K., Minamishima, T., Sakata, K., Satoh, T., & Yoshino, H. (2019) · Hypertension Research · doi:10.1038/s41440-018-0204-4 · Cited by 10 · see citing works
Kidneys in heart failure: Impact of flozins
Stompór, T. P., & Winiarska, A. (2023) · Kardiologia Polska · doi:10.33963/v.kp.97844 · Cited by 8 · see citing works
Janssens, U., & Joannidis, M. (2016) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-016-0159-7 · Cited by 8 · see citing works
Naegele, M., Flammer, A. J., Enseleit, F., & Ruschitzka, F. T. (2016) · Swiss Medical Weekly · doi:10.4414/smw.2016.14295 · Cited by 8 · see citing works
Beta-blocker therapy in elderly patients with renal dysfunction and heart failure.
Martínez‐Milla, J., Cortés, M., Palfy, J. A., Urquía, M. T., Castillo, M. L., Devesa, A., Rivero, A. L., Mariscal, M. L. M., Jiménez-Varas, I., Figuero, S. B., et al. (2021) · PubMed Central · doi:10.11909/j.issn.1671-5411.2021.01.005 · Cited by 8 · see citing works
Chen, Y., Hang, C., Su, C.-H., Wu, P., Chen, H., Fang, H., Fang, Y., Cheng, C., Fu, M., & Chen, S. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.55119 · Cited by 8 · see citing works
Management of Hyperkalemia in Heart Failure
Altay, H., Çavuşoğlu, Y., Çelik, A., Demir, Ş., Adana Devlet Hastanesi, K. K., Kılıçarslan, B., Tepecik Egitim ve Arastirma Hastanesi, K. K., Nalbantgil, S., Temizhan, A., Tokgöz, B., et al. (2021) · Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology · doi:10.5543/tkda.2021.s1 · Cited by 8 · see citing works
Burden and challenges of heart failure in patients with chronic kidney disease. A call to action
Romero-González, G. A., Ravassa, S., González, O., Lorenzo, I., Rojas, M. A., García-Trigo, I., Garcı́a-Fernández, N., Lavilla, J., Martín-Moreno, P. L., López, B., et al. (2020) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2020.06.006 · Cited by 9 · see citing works
Lemor, A., Hernandez, G. A., Lee, S. Y., Patel, N., Blumer, V. L., Badiye, A. P., Alfonso, C., Fonarow, G. C., Lindenfeld, J., & Chaparro, S. V. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.02.117 · Cited by 8 · see citing works
Correale, M., Salzano, A., Tricarico, L., Cittadini, A., Crisci, G., Dattilo, G., Inciardi, R. M., Fiori, E., Paolillo, S., Ruocco, G. M., et al. (2025) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2025.106457 · Cited by 7 · see citing works
Pascual-Figal, D. A., & Bayés‐Genís, A. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1439696 · Cited by 7 · see citing works
Prevention of Heart Failure in Patients with Chronic Kidney Disease
Raghban, A., Kirsop, J., & Tang, W. H. W. (2014) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-014-0428-z · Cited by 7 · see citing works
Self-citationWetmore, J. B., Tang, F., Sharma, A., Jones, P. G., & Spertus, J. A. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.07.019 · Cited by 7 · see citing works
Roca, L. N., Cortés, M., Germán, J. B., Becerra, A. J. B., Otero, J. M. R., Chapel, J. A. E., López, C. R., Lázaro, A. M. P., Urquía, M. T., & Tuñón, J. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13164772 · Cited by 6 · see citing works
Tratamiento de la insuficiencia cardiaca en el paciente con insuficiencia renal avanzada
Górriz, J. L., Rico, M. G., & Núñez, J. E. (2019) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(20)30007-8 · Cited by 6 · see citing works
Renal function and vericiguat in heart failure patients: light at the end of the tunnel!
Abdin, A., & Böhm, M. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2280 · Cited by 6 · see citing works
Ros, M. L., Aguilar-Gallardo, J. S., Shah, A., Narasimhan, B., & Aronow, W. S. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2138744 · Cited by 5 · see citing works
Disease-modifier Drugs in Patients with Advanced Heart Failure
Iacoviello, M., Vitale, E., Corbo, M. D., Correale, M., & Brunetti, N. D. (2021) · Heart Failure Clinics · doi:10.1016/j.hfc.2021.05.002 · Cited by 5 · see citing works
Litwin, S. E., & East, C. A. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1058998 · Cited by 5 · see citing works
Renal effects of sacubitril/valsartan in patients with diabetes
Störk, S. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30142-6 · Cited by 5 · see citing works
Pecoits‐Filho, R., Wong, M., Moorthy, M., Banerjee, D., Behera, S., Cálice-Silva, V., Chothia, M., Colbert, G. B., Gulati, M., Herzog, C. A., et al. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2024.100663 · Cited by 3 · see citing works
Parmar, S., Lopez, T., Shah, R., Murphy, D., Warrens, H., Khairallah, M. K., Anderson, L., Rosano, G. M. C., Ster, I. C., & Banerjee, D. (2025) · Cardiorenal Medicine · doi:10.1159/000541806 · Cited by 3 · see citing works
Bosselmann, H. S., Tønder, N., Sölétormos, G., Gaborit, F., Rossing, K., Iversen, K. K., Goetze, J. P., Gustafsson, F., & Schou, M. (2017) · ESC Heart Failure · doi:10.1002/ehf2.12186 · Cited by 3 · see citing works
Gaps in the Heart Failure Guidelines
Tran, B. G., & Fonarow, G. C. (2015) · Cardiac failure review · doi:10.15420/cfr.2015.01.01.50 · Cited by 3 · see citing works
Romero-Farina, G., Aguadé‐Bruix, S., Ródenas‐Alesina, E., Herrador, L., Jordán, P., & González, I. F. (2022) · Journal of Nuclear Cardiology · doi:10.1007/s12350-022-03074-6 · Cited by 3 · see citing works
Bellicini, M. G. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm45741 · Cited by 2 · see citing works
Optimization of digitalis therapy in clinical practice
Diadyk, A. I., Ефременко, В. А., Евгеньевна, К. Т., Мальцева, Н. В., & Приколота, О. А. (2018) · Kardiologiia · doi:10.18087/cardio.2454 · Cited by 2 · see citing works
- Authors
- Damman, K., Tang, W. H. W., Felker, G. M., Lassus, J., Zannad, F., Krum, H., & McMurray, J. J. V.
- Affiliations
- University Medical Center Groningen (NL)
- Cleveland Clinic (US)
- Duke University (US)
- Helsinki University Hospital (FI)
- Inserm (FR)
- Monash University (AU)
- University of Glasgow (GB)
- Corresponding author
- Damman, Kevin
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2014-03
- Volume
- 63
- Issue
- 9
- Pages
- 853-871
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2117478922
- Cited by
- 122
- References
- 90
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 3 · 2023: 3 · 2022: 11 · 2021: 12 · 2020: 11 · 2019: 16 · 2018: 10 · 2017: 9 · 2016: 15 · 2015: 13 · 2014: 3 · 2012: 1
- FWCI
- 1.76
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- Funders
- Netherlands Heart Institute
- European Society of Cardiology Heart Failure Association Research Grant
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- chronic systolic heart failure, chronic kidney disease, renal failure, evidence-based treatment, treatment outcomes, CKD stages 3-5, personalized treatment
- MeSH terms
- Mineralocorticoid Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Electrolytes, Glomerular Filtration Rate, Humans, Renin-Angiotensin System, Risk, Randomized Controlled Trials as Topic, Treatment Outcome, Evidence-Based Medicine, Renal Insufficiency, Heart Failure, Systolic, Angiotensin Receptor Antagonists, Cardiac Resynchronization Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
